Details of the Drug
General Information of Drug (ID: DMCRQ29)
Drug Name |
S-benzo[d]oxazol-2-yl O-butyl carbonothioate
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
MLS000105935; butyl 1,3-benzoxazol-2-ylsulfanylformate; SMR000102909; AC1M2XFY; CHEMBL1253382; cid_2202888; BDBM33627; MolPort-002-144-521; HMS2405D05; HMS1580J19; ZINC2848864; MCULE-9572612001; butyl 1,3-benzoxazol-2-ylsulfanylmethanoate; AB00080574-01; (1,3-benzoxazol-2-ylthio)formic acid butyl ester
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 251.3 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 4 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 6 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 5 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||